Reversible severe fatty liver induced by capecitabine: A case report

RATIONALE: Capecitabine (CAP) is a chemotherapeutic agent used to treat breast and gastrointestinal cancers. The most common adverse reactions of CAP primarily included gastrointestinal and dermatological effects. Whereas, the CAP-induced fatty liver had never been reported. PATIENT CONCERNS: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yiyan, He, Qiancheng, Li, Suxia, Shi, Chang, Yang, Xiaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704805/
https://www.ncbi.nlm.nih.gov/pubmed/29145260
http://dx.doi.org/10.1097/MD.0000000000008547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704805/
https://www.ncbi.nlm.nih.gov/pubmed/29145260
http://dx.doi.org/10.1097/MD.0000000000008547

Ejemplares similares